| Literature DB >> 2825264 |
M Just1, P Gutjahr, H P Higer, S Störkel, J Rudigier, G Ritter, P Pfannenstiel.
Abstract
The value of MRI as a method for controlling treatment quantitatively was studied in four osteosarcomas and one Ewing sarcoma. Histologically proven change resulting from chemotherapy (2 patients) correlated with a significant increase in T2 of tumour tissue. In three other patients who did not respond to therapy, no change could be demonstrated. MRI appears to be valuable as a non-invasive method for monitoring treatment.Entities:
Mesh：
Year: 1987 PMID： 2825264 DOI： 10.1055/s-2008-1048667
Source DB: PubMed Journal: Rofo ISSN： 1438-9010